A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

May 1, 2027

Conditions

Vestibular MigraineAdults 18 Years and Older (no Other Exclusion Criteria)

Interventions

DRUG

Rimegepant

Take 75mg qd of oral sulfate remigipan orally disintegrating tablets

DRUG

Placebo

Take 75mg qd of oral Rimegepan oral tablets with placebo

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER